Inhalation Powder articles & resources on Made-in-China.com

Afrezza Hopes That Its Inhalable Insulin Product Will Be a Gamechanger for Diabetics

Apr 8, 2014

Afrezza hopes that its inhalable insulin product will be a gamechanger for diabetics. (Image courtesy Afrezza). Insulin injections may soon be a thing of the past if Mannkind Corp.'s inhalable insulin product, Afrezza, is approved by ...

Tags: Health, Medicine

Anoro Ellipta Has Been Approved by FDA for Once-Daily Treatment of COPD

Dec 25, 2013

Anoro Ellipta (umeclidinium and vilanterol inhalation powder) has been approved by the U.S. Food and Drug Administration for once-daily treatment of chronic obstructive pulmonary disease (COPD). COPD, an umbrella term that includes the ...

Tags: Anoro Ellipta

CFFT Has Provided $1.7m Research Award to US-based Savara Pharmaceuticals

Oct 21, 2013

Cystic Fibrosis Foundation Therapeutics (CFFT), an affiliate of the CF Foundation, has provided $1.7m research award to US-based Savara Pharmaceuticals for advancing the development of AeroVanc (vancomycin hydrochloride inhalation powder). ...

Tags: Savara Pharmaceuticals, Aerovanc Development

MannKind Has Resubmitted a New Drug Application to The FDA

Oct 16, 2013

US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...

Tags: Insulin Application, biopharmaceutical company MannKind

Grupo Ferrer Internacional Has Begun Sales of Adasuve Inhalation Powder

Aug 2, 2013

Grupo Ferrer Internacional, Alexza Pharmaceuticals' commercial partner, has begun sales of Adasuve inhalation powder, pre-dispensed (Staccato Loxapine) in the European Union (EU). The first sale triggered a $1.25m milestone payment to ...

Tags: Inhalation Powder, Grupo

Novartis TOBI Podhaler 28mg Per Capsule Has Obtained FDA Approval

Mar 26, 2013

c (tobramycin inhalation powder) 28mg per capsule has obtained FDA approval for the treatment of bacterial lung infection in certain cystic fibrosis (CF) patients. TOBI Podhaler is new non-nebulized formulation and delivery system of ...

Tags: FDA, cystic fibrosis patients, lung infection

AIDAC to The US FDA Has Recommended The Use of Novartis's TIP

Nov 29, 2012

The Anti-Infective Drugs Advisory Committee (AIDAC) to the US Food and Drug Administration (FDA) has recommended the use of Novartis's tobramycin inhalation powder (TIP) to treat cystic fibrosis (CF) patients whose lungs contain bacteria ...

Tags: AIDAC, TIP, CF